litlas
ログインアカウント作成

John Zalcberg

1986–2025 年に発表

129
論文数
26,407
被引用数
67
h 指数
122
i10 指数

被引用数

John Zalcberg の年別被引用数1958 年: 被引用 1 件1987 年: 被引用 2 件1988 年: 被引用 3 件1989 年: 被引用 1 件1990 年: 被引用 2 件1991 年: 被引用 4 件1992 年: 被引用 3 件1993 年: 被引用 1 件1994 年: 被引用 3 件1995 年: 被引用 4 件1996 年: 被引用 6 件1997 年: 被引用 5 件1998 年: 被引用 13 件1999 年: 被引用 29 件2000 年: 被引用 31 件2001 年: 被引用 28 件2002 年: 被引用 31 件2003 年: 被引用 41 件2004 年: 被引用 33 件2005 年: 被引用 50 件2006 年: 被引用 74 件2007 年: 被引用 88 件2008 年: 被引用 133 件2009 年: 被引用 199 件2010 年: 被引用 223 件2011 年: 被引用 224 件2012 年: 被引用 215 件2013 年: 被引用 229 件2014 年: 被引用 259 件2015 年: 被引用 220 件2016 年: 被引用 195 件2017 年: 被引用 270 件2018 年: 被引用 176 件2019 年: 被引用 661 件2020 年: 被引用 632 件2021 年: 被引用 630 件2022 年: 被引用 459 件2023 年: 被引用 365 件2024 年: 被引用 597 件2025 年: 被引用 246 件2026 年: 被引用 7 件1959〜1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,107 件、この内訳の 21.7%中国: 引用元論文 805 件、この内訳の 8.3%イギリス: 引用元論文 704 件、この内訳の 7.3%イタリア: 引用元論文 586 件、この内訳の 6.1%ドイツ: 引用元論文 542 件、この内訳の 5.6%日本: 引用元論文 456 件、この内訳の 4.7%フランス: 引用元論文 438 件、この内訳の 4.5%オランダ: 引用元論文 422 件、この内訳の 4.4%オーストラリア: 引用元論文 390 件、この内訳の 4%スペイン: 引用元論文 339 件、この内訳の 3.5%カナダ: 引用元論文 292 件、この内訳の 3%ベルギー: 引用元論文 266 件、この内訳の 2.7%
0%21.7%その他 24.2%

機関

分野

  • Medicine74.8%
  • Biochemistry, Genetics and Molecular Biology16.7%
  • Immunology and Microbiology2.1%
  • Economics, Econometrics and Finance1.1%
  • Computer Science0.8%
  • Mathematics0.7%
  • その他3.8%

トピック

  • Colorectal Cancer Treatments and Studies7.2%
  • Gastric Cancer Management and Outcomes5.6%
  • Gastrointestinal Tumor Research and Treatment4.1%
  • Esophageal Cancer Research and Treatment3.8%
  • Colorectal Cancer Surgical Treatments3%
  • Cancer Genomics and Diagnostics2.8%
  • その他73.5%

共著者

全論文

検索で開く
  1. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

    著者: Charles S. Fuchs, Jiří Tomášek, Cho Jae Yong, Filip Dumitru, Rodolfo Passalacqua, Chanchal Goswami, Howard Safran, Lucas Vieira dos Santos, Giuseppe Aprile, David Ferry, Bohuslav Melichar, Mustapha Tehfé, Э. Э. Топузов, John Zalcberg, Ian Chau, William Campbell, Choondal Devan Sivanandan, Joanna Pikiel, Minori Koshiji, Yanzhi Hsu, Astra M. Liepa, Ling Gao, Jonathan D. Schwartz, Josep Tabernero - The Lancet 2013 被引用: 2,200

  2. K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

    著者: Christos S. Karapetis, Shirin Khambata‐Ford, Derek J. Jonker, Chris J. O’Callaghan, Dongsheng Tu, Niall C. Tebbutt, R. J. Simes, Haji Chalchal, Jeremy Shapiro, Sonia Robitaille, Timothy Price, Lois E. Shepherd, Heather‐Jane Au, Christiane Langer, Malcolm J. Moore, John Zalcberg - New England Journal of Medicine 2008 被引用: 3,597

  3. Cetuximab for the Treatment of Colorectal Cancer

    著者: Derek J. Jonker, Chris J. O’Callaghan, Christos S. Karapetis, John Zalcberg, Dongsheng Tu, Heather-Jane Au, Scott Berry, Marianne Krahn, Timothy Price, R. J. Simes, Niall C. Tebbutt, Guy van Hazel, Rafal Wierzbicki, Christiane Langer, Malcolm J. Moore - New England Journal of Medicine 2007 被引用: 1,806

  4. Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04

    著者: Samuel Y. Ngan, Bryan Burmeister, Richard Fisher, Michael J. Solomon, David Goldstein, David Joseph, Stephen P. Ackland, David Schache, Bev McClure, Sue‐Anne McLachlan, Joseph McKendrick, Trevor Leong, Cris Hartopeanu, John Zalcberg, John Mackay - Journal of Clinical Oncology 2012 被引用: 920

  5. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

    著者: Jean‐Yves Blay, César Serrano, Michael C. Heinrich, John Zalcberg, Sebastian Bauer, Hans Gelderblom, Patrick Schöffski, Robin L. Jones, Steven Attia, Gina Z. D’Amato, Ping Chi, Peter Reichardt, Julie Meade, Kelvin Shi, Rodrigo Ruiz‐Soto, Suzanne George, Margaret von Mehren - The Lancet Oncology 2020 被引用: 407

  6. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

    著者: Katrin Marie Sjoquist, Bryan Burmeister, B. Mark Smithers, John Zalcberg, R. J. Simes, Andrew P. Barbour, Val Gebski - The Lancet Oncology 2011 被引用: 1,662

  7. Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial

    著者: Derek J. Jonker, Louise Nott, Takayuki Yoshino, Sharlene Gill, Jeremy Shapiro, Atsushi Ohtsu, John Zalcberg, Michael M. Vickers, Alice C. Wei, Yuan Gao, Niall C. Tebbutt, Ben Markman, Timothy Price, Taito Esaki, Sheryl Koski, Matthew Hitron, Wěi Li, Youzhi Li, Nadine M Magoski, Chiang J. Li, John Simes, Dongsheng Tu, Christopher J. O’Callaghan - ˜The œLancet. Gastroenterology & hepatology 2018 被引用: 168

  8. Delivering affordable cancer care in high-income countries

    著者: Richard Sullivan, Jeffrey Peppercorn, Karol Sikora, John Zalcberg, Neal J. Meropol, Eitan Amir, David Khayat, Peter Boyle, Philippe Autier, Ian F. Tannock, Tito Fojo, Jim Siderov, Steve Williamson, Silvia Camporesi, J. Gordon McVie, Arnie Purushotham, Peter Naredi, Alexander Eggermont, Murray F. Brennan, Michael L. Steinberg, Mark De Ridder, Susan A. McCloskey, Dirk Verellen, Terence Roberts, Guy Storme, Rodney J. Hicks, Peter J. Ell, Bradford R. Hirsch, David P. Carbone, Kevin A. Schulman, Paul Catchpole, David Taylor, Jan Geißler, Nancy Brinker, David Meltzer, David Kerr, Matti Aapro - The Lancet Oncology 2011 被引用: 714

  9. Cell graph neural networks enable the precise prediction of patient survival in gastric cancer

    著者: Yanan Wang, Yu Guang Wang, Changyuan Hu, Ming Li, Yanan Fan, Nina Otter, Ikuan Sam, Hongquan Gou, Yiqun Hu, Terry Kwok, John Zalcberg, Alex Boussioutas, Roger J. Daly, Guido Montúfar, Píetro Lió, Dakang Xu, Geoffrey I. Webb, Jiangning Song - npj Precision Oncology 2022 被引用: 65

  10. A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours

    著者: Yoon‐Jung Kang, Sophie O’Haire, Fanny Franchini, Maarten J. IJzerman, John Zalcberg, Finlay Macrae, Karen Canfell, Julia Steinberg - Scientific Reports 2022 被引用: 77

  11. Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial

    著者: Sebastian Bauer, Robin L. Jones, Jean‐Yves Blay, Hans Gelderblom, Suzanne George, Patrick Schöffski, Margaret von Mehren, John Zalcberg, Yoon‐Koo Kang, Albiruni Abdul Razak, Jonathan C. Trent, Steven Attia, Axel Le Cesne, Ying Su, Julie Meade, Tao Wang, Matthew L. Sherman, Rodrigo Ruiz‐Soto, Michael C. Heinrich - Journal of Clinical Oncology 2022 被引用: 111

  12. Effect of Aspirin on Cancer Incidence and Mortality in Older Adults

    著者: John J. McNeil, Peter Gibbs, Suzanne G. Orchard, Jessica E. Lockery, Wendy B. Bernstein, Yin Cao, Leslie G. Ford, Andrew Haydon, Brenda Kirpach, Finlay Macrae, Catriona McLean, Jeremy Millar, Anne M. Murray, Mark Nelson, Galina Polekhina, Christopher M. Reid, Ellen Richmond, Luz M. Rodriguez, Raj C. Shah, Jeanne Tie, Asad Umar, G. J. van Londen, Kathlyn J. Ronaldson, Rory Wolfe, Robyn L. Woods, John Zalcberg, Andrew T. Chan, the ASPREE Investigator Group - JNCI Journal of the National Cancer Institute 2020 被引用: 145

  13. Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

    著者: Wendy De Roock, Derek J. Jonker, Federica Di Nicolantonio, Andrea Sartore‐Bianchi, Dongsheng Tu, Salvatore Siena, Simona Lamba, Sabrina Arena, Milo Frattini, Hubert Piessevaux, Eric Van Cutsem, Chris J. O’Callaghan, Shirin Khambata‐Ford, John Zalcberg, John Simes, Christos S. Karapetis, Alberto Bardelli, Sabine Tejpar - JAMA 2010 被引用: 747

  14. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

    著者: Jaap Verweij, Paolo G. Casali, John Zalcberg, A. Lecesne, Peter Reichardt, Jean‐Yves Blay, Rolf D. Issels, A. van Oosterom, Pancras C.W. Hogendoorn, M. van Glabbeke, Rossella Bertulli, Ian Judson - The Lancet 2004 被引用: 1,668

  15. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

    著者: Maria Dêbiec‐Rychter, Raf Sciot, Axel Le Cesne, M. Schlemmer, Peter Hohenberger, Allan T. van Oosterom, Jean‐Yves Blay, Serge Leyvraz, Michel Stul, Paolo G. Casali, John Zalcberg, Jaap Verweij, M. van Glabbeke, Anne Hagemeijer, Ian Judson - European Journal of Cancer 2006 被引用: 899

  16. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

    著者: George D. Demetri, Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón, Angelo Paolo Dei Tos, Jayesh Desai, Jonathan A. Fletcher, Hans Gelderblom, Suzanne George, Alessandro Gronchi, Rick L. Haas, Nadia Hindi, Peter Hohenberger, Heikki Joensuu, Robin L. Jones, Ian Judson, Y-K Kang, Akira Kawai, Alexander J. Lazar, Axel Le Cesne, Roberta Maestro, Robert G. Maki, Javier Martín‐Broto, Shreyaskumar Patel, Frédérique Penault‐Llorca, Chandrajit P. Raut, Piotr Rutkowski, Akmal Safwat, Marta Sbaraglia, Inga‐Marie Schaefer, Lin Shen, César Serrano, P. Schöffski, Silvia Stacchiotti, Kirsten Sundby Hall, William D. Tap, David M. Thomas, Jonathan C. Trent, Claudia Valverde, Winette T.A. van der Graaf, M. von Mehren, Andrew J. Wagner, E. Wardelmann, Yoichi Naito, John Zalcberg, Jean‐Yves Blay - Annals of Oncology 2020 被引用: 145

  17. Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17

    著者: Stephanie Yasmin Brule, Derek J. Jonker, Christos S. Karapetis, Chris J. O’Callaghan, Malcolm J. Moore, Ralph Wong, Niall C. Tebbutt, Craig Underhill, Desmond Yip, John Zalcberg, Dongsheng Tu, Rachel Goodwin - European Journal of Cancer 2015 被引用: 337

  18. Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 study

    著者: Robert Carroll, Michael Boyer, Val Gebski, Bronwyn Hockley, Julie Johnston, Svjetlana Kireta, Hsiang Tan, Anne E. Taylor, Kate Wyburn, John Zalcberg - The Lancet Oncology 2022 被引用: 87

  19. Functional Decline in the Cancer Patient: A Review

    著者: Jaidyn Muhandiramge, Suzanne G. Orchard, Erica T. Warner, G. J. van Londen, John Zalcberg - Cancers 2022 被引用: 118

  20. Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial

    著者: Michael C. Heinrich, Robin L. Jones, Suzanne George, Hans Gelderblom, Patrick Schöffski, Margaret von Mehren, John Zalcberg, Yoon‐Koo Kang, Albiruni Abdul Razak, Jonathan C. Trent, Steven Attia, Axel Le Cesne, Brittany L. Siontis, David Goldstein, Kjetil Boye, César Sánchez, Neeltje Steeghs, Piotr Rutkowski, Mihaela Druta, César Serrano, Neeta Somaiah, Ping Chi, William M. Reichmann, Kam Sprott, Haroun Achour, Matthew L. Sherman, Rodrigo Ruiz‐Soto, Jean‐Yves Blay, Sebastian Bauer - Nature Medicine 2024 被引用: 52

  21. Non-aspirin non-steroidal anti-inflammatory drugs in colorectal cancer: a review of clinical studies

    著者: Farzana Y. Zaman, Suzanne G. Orchard, Andrew Haydon, John Zalcberg - British Journal of Cancer 2022 被引用: 37

  22. Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels

    著者: Paolo G. Casali, John Zalcberg, Axel Le Cesne, Peter Reichardt, Jean‐Yves Blay, Lars H. Lindner, Ian Judson, Patrick Schöffski, Serge Leyvraz, Antoîne Italiano, Viktor Grünwald, Antonio López–Pousa, Dusan Kotasek, Stefan Sleijfer, J. Martijn Kerst, Piotr Rutkowski, Elena Fumagalli, Pancras C.W. Hogendoorn, Saskia Litière, Sandrine Marréaud, Winette van der Graaf, Alessandro Gronchi, Jaap Verweij - Journal of Clinical Oncology 2017 被引用: 193

  23. Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD

    著者: Hans‐Joachim Schmoll, Alexander Stein, Eric Van Cutsem, Timothy Price, Ralf‐Dieter Hofheinz, Bernard Nordlinger, Jean‐François Daisne, Jos Janssens, Baruch Brenner, H. Reinel, Stephan Hollerbach, Karel Caca, F. Fauth, Carla Hannig, John Zalcberg, Niall C. Tebbutt, Murielle Mauer, Sandrine Marréaud, Manfred P. Lutz, Karin Haustermans - Journal of Clinical Oncology 2020 被引用: 97

  24. Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology

    著者: Jaidyn Muhandiramge, John Zalcberg, G. J. van Londen, Erica T. Warner, Prudence R. Carr, Andrew Haydon, Suzanne G. Orchard - Current Oncology Reports 2022 被引用: 65